175 related articles for article (PubMed ID: 3040426)
1. The specific opioid kappa-agonist U-50,488H inhibits low Km GTPase.
Ueda H; Misawa H; Fukushima N; Takagi H
Eur J Pharmacol; 1987 Jun; 138(1):129-32. PubMed ID: 3040426
[TBL] [Abstract][Full Text] [Related]
2. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
[TBL] [Abstract][Full Text] [Related]
3. Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat.
Yuan CS
Eur J Pharmacol; 1996 Oct; 314(1-2):27-32. PubMed ID: 8957215
[TBL] [Abstract][Full Text] [Related]
4. Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at mu- and kappa-opioid receptor sites in rabbit and guinea-pig cerebellum membranes.
Frances B; Moisand C; Meunier JC
Eur J Pharmacol; 1985 Nov; 117(2):223-32. PubMed ID: 2866971
[TBL] [Abstract][Full Text] [Related]
5. Effects of mu-, delta- and kappa-agonists on isolated right atria of the rat.
Micol JA; Laorden ML
Neuropeptides; 1994 Jun; 26(6):365-70. PubMed ID: 7936123
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of mu, delta, and kappa opioid agonists on adenylate cyclase activity.
De Montis GM; Devoto P; Preti A; Tagliamonte A
J Neurosci Res; 1987; 17(4):435-9. PubMed ID: 2887665
[TBL] [Abstract][Full Text] [Related]
7. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
Grider JR; Makhlouf GM
Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
[TBL] [Abstract][Full Text] [Related]
8. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs.
Werling LL; Frattali A; Portoghese PS; Takemori AE; Cox BM
J Pharmacol Exp Ther; 1988 Jul; 246(1):282-6. PubMed ID: 2839666
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
Pugsley MK; Penz WP; Walker MJ; Wong TM
Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
[TBL] [Abstract][Full Text] [Related]
10. Modulation of kappa-opioid receptor mediated tolerance in the guinea-pig ileum by chronic co-administration of dihydropyridines.
Garaulet JV; Laorden ML; Milanés MV
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):72-9. PubMed ID: 8832591
[TBL] [Abstract][Full Text] [Related]
11. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
Capasso A; Sorrentino L; Pinto A
Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
[TBL] [Abstract][Full Text] [Related]
12. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
[TBL] [Abstract][Full Text] [Related]
13. Effects of prior exposure to morphine on the opioid inhibition of the stimulated release of [3H]norepinephrine from guinea pig cortex slices.
Werling LL; Brown SR; Cox BM
NIDA Res Monogr; 1986; 75():587-90. PubMed ID: 2829006
[TBL] [Abstract][Full Text] [Related]
14. Inability of an opioid antagonist lacking negative intrinsic activity to induce opioid receptor up-regulation in vivo.
Morris BJ; Millan MJ
Br J Pharmacol; 1991 Apr; 102(4):883-6. PubMed ID: 1649659
[TBL] [Abstract][Full Text] [Related]
15. Opioid receptor regulation of the release of norepinephrine in brain.
Werling LL; Brown SR; Cox BM
Neuropharmacology; 1987 Jul; 26(7B):987-96. PubMed ID: 2821438
[TBL] [Abstract][Full Text] [Related]
16. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
Wilson JL; Nayanar V; Walker JS
Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the opioid receptor subtypes mediating the negative inotropic effects of DAMGO, DPDPE and U-50, 488H in isolated human right atria strips.
Llobell F; Laorden ML
Neuropeptides; 1995 Aug; 29(2):115-9. PubMed ID: 7477762
[TBL] [Abstract][Full Text] [Related]
18. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
Devine DP; Leone P; Pocock D; Wise RA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
[TBL] [Abstract][Full Text] [Related]
19. Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist.
Ukai M; Kameyama T
Brain Res; 1985 Jul; 337(2):352-6. PubMed ID: 2992682
[TBL] [Abstract][Full Text] [Related]
20. Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes.
Stiene-Martin A; Zhou R; Hauser KF
Glia; 1998 Mar; 22(3):249-59. PubMed ID: 9482211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]